A real-world study in Germany in multiple myeloma patients treated with protease inhibitors (bortezomib, carfilzomib, or ixazomib) in the second or third therapy
Latest Information Update: 28 Jul 2020
At a glance
- Drugs Bortezomib (Primary) ; Carfilzomib (Primary) ; Ixazomib (Primary) ; Cyclophosphamide; Dexamethasone; Lenalidomide
- Indications Multiple myeloma
- Focus Therapeutic Use
- 28 Jul 2020 New trial record
- 12 Jul 2020 Results published in the Oncology Research and Treatment